Gene · 7879
Papers2,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Dissection of Phagocytosis by Proteomic Analysis in Entamoeba histolytica. | Genes (Basel) | 2023 | 36833306 | PubTator, text mining | PubMed |
| The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer. | Cancers (Basel) | 2023 | 36831441 | PubTator, text mining | PubMed |
| Lithium in Cancer Therapy: Friend or Foe? | Cancers (Basel) | 2023 | 36831437 | PubTator, text mining | PubMed |
| Hyperactivation of p21-Activated Kinases in Human Cancer and Therapeutic Sensitivity. | Biomedicines | 2023 | 36830998 | PubTator, text mining | PubMed |
| The Extracellular Vesicles Proteome of Endometrial Cells Simulating the Receptive Menstrual Phase Differs from That of Endometrial Cells Simulating the Non-Receptive Menstrual Phase. | Biomolecules | 2023 | 36830648 | PubTator, text mining | PubMed |
| Recent Advances in Cellular Signaling Interplay between Redox Metabolism and Autophagy Modulation in Cancer: An Overview of Molecular Mechanisms and Therapeutic Interventions. | Antioxidants (Basel) | 2023 | 36829987 | PubTator, text mining | PubMed |
| The Effect of Carnosine on UVA-Induced Changes in Intracellular Signaling of Human Skin Fibroblast Spheroids. | Antioxidants (Basel) | 2023 | 36829859 | PubTator, text mining | PubMed |
| The synthetic TRPML1 agonist ML-SA1 rescues Alzheimer-related alterations of the endosomal-autophagic-lysosomal system. | J Cell Sci | 2023 | 36825945 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Dermal Fibroblasts Derived From Visceral Leishmaniasis and Post-Kala-Azar Dermal Leishmaniasis Patients Reveal Disease-Specific Gene Expression and Pathological Regulation. | J Infect Dis | 2023 | 36821723 | PubTator, text mining | PubMed |
| MSC-Exos: Important active factor of bone regeneration. | Front Bioeng Biotechnol | 2023 | 36814713 | PubTator, text mining | PubMed |
| MTSS1 curtails lung adenocarcinoma immune evasion by promoting AIP4-mediated PD-L1 monoubiquitination and lysosomal degradation. | Cell Discov | 2023 | 36810288 | PubTator, text mining | PubMed |
| Magnetic transferrin nanoparticles (MTNs) assay as a novel isolation approach for exosomal biomarkers in neurological diseases. | Biomater Res | 2023 | 36797805 | PubTator, text mining | PubMed |
| Synthetic analysis of chromatin tracing and live-cell imaging indicates pervasive spatial coupling between genes. | Elife | 2023 | 36790144 | PubTator, text mining | PubMed |
| The role of fatty acid desaturase 2 in multiple tumor types revealed by bulk and single-cell transcriptomes. | Lipids Health Dis | 2023 | 36788618 | PubTator, text mining | PubMed |
| DNA methylation changes and increased mRNA expression of coagulation proteins, factor V and thrombomodulin in Fuchs endothelial corneal dystrophy. | Cell Mol Life Sci | 2023 | 36773096 | PubTator, text mining | PubMed |
| Label-Free Mass Spectrometry Proteomics Reveals Different Pathways Modulated in THP-1 Cells Infected with Therapeutic Failure and Drug Resistance Leishmania infantum Clinical Isolates. | ACS Infect Dis | 2023 | 36762976 | PubTator, text mining | PubMed |
| EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer. | J Clin Invest | 2023 | 36757799 | PubTator, text mining | PubMed |
| Network-based quantitative trait linkage analysis of microbiome composition in inflammatory bowel disease families. | Front Genet | 2023 | 36755569 | PubTator, text mining | PubMed |
| Rab7a-mTORC1 signaling-mediated cholesterol trafficking from the lysosome to mitochondria ameliorates hepatic lipotoxicity induced by aflatoxin B1 exposure. | Chemosphere | 2023 | 36754296 | PubTator, text mining | PubMed |
| Role of transcription factors in apoptotic cells clearance. | Front Cell Dev Biol | 2023 | 36743409 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7879/papers?page=17